Literature DB >> 9141736

Towards guidelines for survey research in remote Aboriginal communities.

R J Donovan1, R Spark.   

Abstract

Based on our experience in developing and evaluating community-based health promotion programs in Aboriginal and Torres Strait Islander communities, we offer guidelines to assist nonindigenous health and public policy professionals whose information gathering in these communities includes the use of unstructured interviewing or survey questionnaires. The guidelines primarily apply to research among mainland remote Aboriginal communities, but are placed in a cultural context such that those dealing with Torres Strait Islanders and rural or urban community Aborigines also may benefit from the guidelines. The major aims of these guidelines are to facilitate communication between interviewers and indigenous interviewees and to ensure that interviewing is done with maximum sensitivity to cultural differences and with minimum discomfort to the respondents.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  1997        PMID: 9141736     DOI: 10.1111/j.1467-842x.1997.tb01660.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  3 in total

1.  Low back pain risk factors in a large rural Australian Aboriginal community. An opportunity for managing co-morbidities?

Authors:  Dein Vindigni; Bruce F Walker; Jennifer R Jamison; Cliff Da Costa; Lynne Parkinson; Steve Blunden
Journal:  Chiropr Osteopat       Date:  2005-09-30

2.  Australian Aboriginal and Torres Strait Islander-focused primary healthcare social and emotional wellbeing research: a systematic review protocol.

Authors:  Sara Farnbach; Anne-Marie Eades; Maree Lisa Hackett
Journal:  Syst Rev       Date:  2015-12-30

3.  Knowledge of and preferred sources of assistance for physical activity in a sample of urban Indigenous Australians.

Authors:  Alison L Marshall; Julian Hunt; David Jenkins
Journal:  Int J Behav Nutr Phys Act       Date:  2008-04-28       Impact factor: 6.457

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.